PANACHE

This brand name is authorized in Nigeria.

Active ingredients

The drug PANACHE contains one active pharmaceutical ingredient (API):

1	Ketorolac UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE
	Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.
	Read more about Ketorolac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9056	Injection	Panache Injection INJ 30 mg 51ML	Panache Injection KETOROLAC TROMETHAMINE 30MG Ketorolac Thrometamine 30mg Water for Injection BP q.s Absolute Alcohol (Dehydrate IH) Sodium Hydroxide Pellets BP Hydrochloric Acid BP Sodium Chloride BP Water for injections BP Q.S B4-9056 Drugs Imported Products 51ML Prescription Only Medicine (POM) 08/05/2023 SUPERIOR PHARMACEUTICALS LIMITED, 9B, ROBINSON GBAGI STREET, AJAO ESTATE 8029403780 superiorpharmang@gmail.com Akum Drug & Pharma Ltd, 2,3,4&Sector -6B I.I.E, SIDCUL HARIDWAR -249 403 INDIA, India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB15	Ketorolac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9056